Go to the list of all blogs
published in Blogs
Apr 21, 2026

RTX (RTX): +7% YTD Gains on Q1 Earnings Beat and $11.9 Billion Defense Deal

Key Takeaways

  • RTX reported Q1 2026 earnings that significantly exceeded expectations, with adjusted EPS of $1.78 and revenue of $22.1 billion, leading to raised full-year guidance.
  • A major U.S. approval for a potential $11.9 billion combat systems deal with Germany underscores RTX's role in international defense.
  • Analyst consensus rates the stock as Overweight, with an average price target around $219.
  • Strong demand in munitions and commercial aviation supports ongoing backlog growth and cash flow generation.
  • RTX's $251 billion backlog positions it well amid geopolitical tensions and air travel recovery.

A Snapshot of RTX's Current Market Position

In recent weeks, RTX stock has shown resilience amid broader market fluctuations, supported by strong tailwinds in the aerospace and defense sectors. Trading near the upper end of its 52-week range—with a high of $214.50 and a low of $112.63—the shares reflect growing investor confidence in the company's execution. Year-to-date gains exceed 7%, fueled by steady demand for military hardware and commercial aftermarket services. With a market capitalization over $263 billion, RTX maintains its position as a leader in high-tech systems. Recent sessions have highlighted positive momentum from operational performance and contract wins, setting the stage for continued interest. I also checked this using Tickeron’s AI Screener to compare how RTX stacks up against peers in the industry.

Recent Developments Driving RTX's Momentum

RTX Corporation has drawn significant investor focus lately, thanks to key operational updates and geopolitical developments. On April 21, 2026, the company posted Q1 results that beat Wall Street estimates, with adjusted EPS of $1.78—surpassing the $1.52 forecast—and revenue of $22.1 billion against expectations of about $21.4 billion. This led RTX to raise its full-year 2026 profit and revenue guidance, pointing to sustained aftermarket sales, strong weapons demand, and commercial aviation growth. Shares climbed over 3% following the news, signaling optimism around execution and supply chain progress.

Adding to the earnings tailwinds, the U.S. State Department approved a potential $11.9 billion sale of combat systems to Germany, involving RTX and Lockheed Martin, announced about 18 hours earlier. This strengthens RTX's international defense presence and highlights rising European security demands. RTX also won a contract for advanced jammers from the Australian government, showcasing its electronic warfare capabilities and expanding footprint in the Asia-Pacific. These wins have helped counter near-term macroeconomic pressures, such as interest rate outlooks. From what I see, patterns like these align with what Tickeron’s AI Trend Prediction Engine has flagged for defense names.

Analyst reactions have been mixed yet generally positive. Jefferies kept a Hold rating on April 13, trimming its target to $210, while the consensus from 26 firms holds at Overweight with an average target of $219.36. Earlier in the quarter, the stock weathered industrial sector volatility but recovered on defense spending strength. No significant guidance changes or SEC filings have hurt the fundamentals. Overall, these factors—solid quarterly results, new contracts, and an upgraded outlook—have driven price gains, supporting RTX's premium valuation in a sector lifted by global tensions and aviation recovery.

Tickeron's Trending AI Robots

In my analysis workflow, I often reference Tickeron’s Trending AI Robots page, which features the top 25 AI-powered trading bots from over 350 on the platform. These bots trade thousands of tickers across stocks, ETFs, and crypto, selected for their strong performance in today's markets with strategies like swing trading, trend following, and volatility plays—spanning timeframes from 5 minutes to 55 days. Key metrics include annualized returns of 15% to 168%, win rates from 54% to 88%, and profit factors up to 11.7. For example, bots focused on Aerospace & Defense tickers such as KTOS and RKLB, plus ETFs like ITA, offer targeted opportunities. This resource helps me review backtests and live results to refine my approach.

RTX's 2026 Outlook and Key Factors to Watch

Looking ahead to 2026, several themes from RTX's January guidance and recent updates warrant close attention. Full-year sales are expected at $92-93 billion, with adjusted EPS of $6.60-$6.80 and free cash flow of $8.25-$8.75 billion, powered by commercial engine aftermarket expansion and defense awards. The record $251 billion backlog offers strong visibility, though progress on Pratt & Whitney's geared turbofan engines remains key after prior supply hurdles.

Upside potential comes from rising defense budgets—especially U.S. and allies' focus on munitions and hypersonics—plus commercial aviation recovery. Risks involve geopolitical changes impacting contracts, raw material inflation, and M&A regulatory hurdles. Success in electronic warfare, next-gen systems, and cost controls will matter. Industry shifts toward sustainable aviation fuels and defense digitalization may provide further support. I'll be tracking quarterly backlog conversion, segment margins, and macro indicators for signs of ongoing strength. One thing that stands out is how this backlog insulates RTX amid uncertainty.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: RTX

RTX in upward trend: price may ascend as a result of having broken its lower Bollinger Band on September 24, 2026

RTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 18 of 26 cases where RTX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 69%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 20 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +0.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where RTX advanced for three days, in 231 of 350 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

Bearish Trend Analysis

RTX moved below its 50-day moving average on September 01, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for RTX crossed bearishly below the 50-day moving average on September 04, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 50%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 44%.

The Aroon Indicator for RTX entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 13 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 47 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. RTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.811) is normal, around the industry mean (6.305). P/E Ratio (33.039) is within average values for comparable stocks, (58.116). Projected Growth (PEG Ratio) (2.176) is also within normal values, averaging (2.564). Dividend Yield (0.015) settles around the average of (0.009) among similar stocks. P/S Ratio (2.868) is also within normal values, averaging (18.330).

The Tickeron SMR rating for this company is 64 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 38.94B. The market cap for tickers in the group ranges from 4.49 to 1.92T. SPCX holds the highest valuation in this group at 1.92T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -1%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was -11%. SPCX experienced the highest price growth at 18%, while PUSA experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 19%. For the same stocks of the Industry, the average monthly volume growth was 41% and the average quarterly volume growth was -24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 45
P/E Growth Rating: 70
Price Growth Rating: 62
SMR Rating: 77
Profit Risk Rating: 76
Seasonality Score: 14 (-100 ... +100)
View a ticker or compare two or three
RTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in the provision of aerospace and defense systems and services for commercial, military, and government customers

Industry AerospaceDefense

Industry
N/A
Address
1000 Wilson Boulevard
Phone
+1 781 522-3000
Employees
180000
Web
https://www.rtx.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.